한글목차

세계의 세라마이드 AP 시장 규모는 2023년에 6,172만 달러로 평가되었습니다.

이 시장은 2024년부터 2030년까지 예측 기간 중에 9.62%의 연평균 복합 성장률(CAGR)로 확대되어 2030년까지 1억 1,393만 달러에 이를 것으로 예측됩니다.

북미 세라마이드 AP 시장 규모는 2023년에 1,294만 달러로 평가되었습니다.이 시장은 2024년부터 2030년까지 예측 기간 중에 6.90%의 연평균 복합 성장률(CAGR)로 확대되어 2030년까지 2,049만 달러에 이를 것으로 예측됩니다.

유럽 세라마이드 AP 시장 규모는 2023년에 1,568만 달러로 평가되었습니다.이 시장은 2024년부터 2030년까지 예측 기간 중에 8.97%의 연평균 복합 성장률(CAGR)로 확대되어 2030년까지 2,762만 달러에 이를 것으로 예측됩니다.

아시아태평양 세라마이드 AP 시장 규모는 2023년에 2,790만 달러로 평가되었습니다.이 시장은 2024년부터 2030년까지 예측 기간 중에 11.21%의 연평균 복합 성장률(CAGR)로 확대되어 2030년까지 5,662만 달러에 이를 것으로 예측됩니다.

세라마이드 AP 세계의 주요 기업에는 Sederma(Croda International), Evonik, Bio-Nest Biochemical Technology Co., LTD, Puripharm Co., Ltd., NIKKOL GROUP등이 포함됩니다. 2023년에는 세계의 대형 5사가 판매량으로 약 67.47%의 점유율을 차지했습니다.

본 보고서는 세라마이드 AP 세계 시장에 대해, 지역·국가별, 유형별, 용도별 분석과 함께, 총판매량, 판매 매출, 가격, 주요 기업의 시장 점유율, 순위를 중심으로 종합적으로 소개하는 것을 목적으로 하고 있습니다.

세계의 세라마이드 AP 시장에 대해 조사했으며, 시장 개요와 함께 유형별, 용도별, 지역별 동향 및 시장 진출기업 개요 등의 정보를 제공합니다.

목차

제1장 시장 개요

• 세라마이드 AP제품 서론
• 세계의 세라마이드 AP 시장 규모 예측
• 세라마이드 AP 시장 동향과 촉진요인
• 전제와 제한
• 조사 목적
• 대상년

제2장 기업의 경쟁 분석

제3장 유형별 세분화

• 유형별 서론
• 세계의 세라마이드 AP 판매액, 유형별
• 세계의 세라마이드 AP 판매량, 유형별
• 세계의 세라마이드 AP 평균 가격, 유형별(2019년-2030년)

제4장 용도별 세분화

• 용도별 서론
• 세계의 세라마이드 AP 판매액, 용도별
• 세계의 세라마이드 AP 판매량, 용도별
• 세계의 세라마이드 AP 평균 가격, 용도별(2019년-2030년)

제5장 지역별 세분화

• 세계의 세라마이드 AP 판매액, 지역별
• 세계의 세라마이드 AP 판매량, 지역별
• 세계의 세라마이드 AP 평균 가격, 지역별(2019년-2030년)
• 북미
• 유럽
• 아시아태평양
• 남미
• 중동 및 아프리카

제6장 주요 국가/지역별 세분화

• 주요 국가/지역별 세라마이드 AP 판매액 성장 동향, 2019년 vs. 2023년 vs. 2030년
• 주요 국가/지역별 세라마이드 AP 판매액수, 2019년-2030년
• 미국
• 유럽
• 중국
• 일본
• 한국
• 동남아시아
• 인도

제7장 기업 개요

• Evonik
• Sederma(Croda International)
• NIKKOL GROUP
• Bio-Nest Biochemical Technology Co., LTD
• Puripharm Co., Ltd.

제8장 산업 체인 분석

제9장 조사 결과와 결론

제10장 부록

영문목차

The global market for CeramideAP was estimated to be worth US$ 61.72 million in 2023 and is forecast to a readjusted size of US$ 113.93 million by 2030 with a CAGR of 9.62% during the forecast period 2024-2030.

North American market for CeramideAP was valued at $ 12.94 million in 2023 and will reach $ 20.49 million by 2030, at a CAGR of 6.90% during the forecast period of 2024 through 2030.

Europe market for CeramideAP was valued at $ 15.68 million in 2023 and will reach $ 27.62 million by 2030, at a CAGR of 8.97 % during the forecast period of 2024 through 2030.

Asia-Pacific market for CeramideAP was valued at $ 27.90 million in 2023 and will reach $ 56.62 million by 2030, at a CAGR of 11.21 % during the forecast period of 2024 through 2030.

The global key companies of CeramideAP include Sederma (Croda International), Evonik, Bio-Nest Biochemical Technology Co., LTD, Puripharm Co., Ltd., NIKKOL GROUP, and etc. In 2023, the global five largest players hold a share approximately 67.47 % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for CeramideAP, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of CeramideAP by region & country, by Type, and by Application.

The CeramideAP market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CeramideAP.

Market Segmentation

By Company

• Evonik
• Sederma (Croda International)
• NIKKOL GROUP
• Bio-Nest Biochemical Technology
• Puripharm

Segment by Type

• Microbial Fermentation
• Chemical Synthesis
• Natural Extraction

Segment by Application

• Cosmetic
• Pharmaceutical Industry

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia-Pacific
• Europe
• Germany
• France
• U.K.
• Italy
• Rest of Europe
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of CeramideAP manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of CeramideAP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of CeramideAP in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 CeramideAP Product Introduction
• 1.2 Global CeramideAP Market Size Forecast
  • 1.2.1 Global CeramideAP Sales Value (2019-2030)
  • 1.2.2 Global CeramideAP Sales Volume (2019-2030)
  • 1.2.3 Global CeramideAP Sales Price (2019-2030)
• 1.3 CeramideAP Market Trends & Drivers
  • 1.3.1 CeramideAP Industry Trends
  • 1.3.2 CeramideAP Market Drivers & Opportunity
  • 1.3.3 CeramideAP Market Challenges
  • 1.3.4 CeramideAP Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global CeramideAP Players Revenue Ranking (2023)
• 2.2 Global CeramideAP Revenue by Company (2019-2024)
• 2.3 Global CeramideAP Players Sales Volume Ranking (2023)
• 2.4 Global CeramideAP Sales Volume by Company Players (2019-2024)
• 2.5 Global CeramideAP Average Price by Company (2019-2024)
• 2.6 Key Manufacturers CeramideAP Manufacturing Base and Headquarters
• 2.7 Establishment Date of Major CeramideAP Manufacturers
• 2.8 CeramideAP Market Competitive Analysis
  • 2.8.1 CeramideAP Market Concentration Rate (2019-2024)
  • 2.8.2 Global 5 Largest Manufacturers by CeramideAP Revenue in 2023
  • 2.8.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CeramideAP as of 2023)
• 2.9 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Microbial Fermentation
  • 3.1.2 Chemical Synthesis
  • 3.1.3 Natural Extraction
• 3.2 Global CeramideAP Sales Value by Type
  • 3.2.1 Global CeramideAP Sales Value by Type (2019 VS 2023 VS 2030)
  • 3.2.2 Global CeramideAP Sales Value, by Type (2019-2030)
  • 3.2.3 Global CeramideAP Sales Value, by Type (%) (2019-2030)
• 3.3 Global CeramideAP Sales Volume by Type
  • 3.3.1 Global CeramideAP Sales Volume by Type (2019 VS 2023 VS 2030)
  • 3.3.2 Global CeramideAP Sales Volume, by Type (2019-2030)
  • 3.3.3 Global CeramideAP Sales Volume, by Type (%) (2019-2030)
• 3.4 Global CeramideAP Average Price by Type (2019-2030)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Cosmetic
  • 4.1.2 Pharmaceutical Industry
• 4.2 Global CeramideAP Sales Value by Application
  • 4.2.1 Global CeramideAP Sales Value by Application (2019 VS 2023 VS 2030)
  • 4.2.2 Global CeramideAP Sales Value, by Application (2019-2030)
  • 4.2.3 Global CeramideAP Sales Value, by Application (%) (2019-2030)
• 4.3 Global CeramideAP Sales Volume by Application
  • 4.3.1 Global CeramideAP Sales Volume by Application (2019 VS 2023 VS 2030)
  • 4.3.2 Global CeramideAP Sales Volume, by Application (2019-2030)
  • 4.3.3 Global CeramideAP Sales Volume, by Application (%) (2019-2030)
• 4.4 Global CeramideAP Average Price by Application (2019-2030)

5 Segmentation by Region

• 5.1 Global CeramideAP Sales Value by Region
  • 5.1.1 Global CeramideAP Sales Value by Region: 2019 VS 2023 VS 2030
  • 5.1.2 Global CeramideAP Sales Value by Region (2019-2024)
  • 5.1.3 Global CeramideAP Sales Value by Region (2025-2030)
  • 5.1.4 Global CeramideAP Sales Value by Region (%), (2019-2030)
• 5.2 Global CeramideAP Sales Volume by Region
  • 5.2.1 Global CeramideAP Sales Volume by Region: 2019 VS 2023 VS 2030
  • 5.2.2 Global CeramideAP Sales Volume by Region (2019-2024)
  • 5.2.3 Global CeramideAP Sales Volume by Region (2025-2030)
  • 5.2.4 Global CeramideAP Sales Volume by Region (%), (2019-2030)
• 5.3 Global CeramideAP Average Price by Region (2019-2030)
• 5.4 North America
  • 5.4.1 North America CeramideAP Sales Value, 2019-2030
  • 5.4.2 North America CeramideAP Sales Value by Country (%), 2023 VS 2030
• 5.5 Europe
  • 5.5.1 Europe CeramideAP Sales Value, 2019-2030
  • 5.5.2 Europe CeramideAP Sales Value by Country (%), 2023 VS 2030
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific CeramideAP Sales Value, 2019-2030
  • 5.6.2 Asia Pacific CeramideAP Sales Value by Region (%), 2023 VS 2030
• 5.7 South America
  • 5.7.1 South America CeramideAP Sales Value, 2019-2030
  • 5.7.2 South America CeramideAP Sales Value by Country (%), 2023 VS 2030
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa CeramideAP Sales Value, 2019-2030
  • 5.8.2 Middle East & Africa CeramideAP Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions CeramideAP Sales Value Growth Trends, 2019 VS 2023 VS 2030
• 6.2 Key Countries/Regions CeramideAP Sales Value, 2019-2030
• 6.3 United States
  • 6.3.1 United States CeramideAP Sales Value, 2019-2030
  • 6.3.2 United States CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.3.3 United States CeramideAP Sales Value by Application, 2023 VS 2030
• 6.4 Europe
  • 6.4.1 Europe CeramideAP Sales Value, 2019-2030
  • 6.4.2 Europe CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.4.3 Europe CeramideAP Sales Value by Application, 2023 VS 2030
• 6.5 China
  • 6.5.1 China CeramideAP Sales Value, 2019-2030
  • 6.5.2 China CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.5.3 China CeramideAP Sales Value by Application, 2023 VS 2030
• 6.6 Japan
  • 6.6.1 Japan CeramideAP Sales Value, 2019-2030
  • 6.6.2 Japan CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.6.3 Japan CeramideAP Sales Value by Application, 2023 VS 2030
• 6.7 South Korea
  • 6.7.1 South Korea CeramideAP Sales Value, 2019-2030
  • 6.7.2 South Korea CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.7.3 South Korea CeramideAP Sales Value by Application, 2023 VS 2030
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia CeramideAP Sales Value, 2019-2030
  • 6.8.2 Southeast Asia CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.8.3 Southeast Asia CeramideAP Sales Value by Application, 2023 VS 2030
• 6.9 India
  • 6.9.1 India CeramideAP Sales Value, 2019-2030
  • 6.9.2 India CeramideAP Sales Value by Type (%), 2023 VS 2030
  • 6.9.3 India CeramideAP Sales Value by Application, 2023 VS 2030

7 Company Profiles

• 7.1 Evonik
  • 7.1.1 Evonik Company Information
  • 7.1.2 Evonik Introduction and Business Overview
  • 7.1.3 Evonik CeramideAP Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.1.4 Evonik CeramideAP Product Offerings
• 7.2 Sederma (Croda International)
  • 7.2.1 Sederma (Croda International) Company Information
  • 7.2.2 Sederma (Croda International) Introduction and Business Overview
  • 7.2.3 Sederma (Croda International) CeramideAP Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.2.4 Sederma (Croda International) CeramideAP Product Offerings
• 7.3 NIKKOL GROUP
  • 7.3.1 NIKKOL GROUP Company Information
  • 7.3.2 NIKKOL GROUP Introduction and Business Overview
  • 7.3.3 NIKKOL GROUP CeramideAP Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.3.4 NIKKOL GROUP CeramideAP Product Offerings
• 7.4 Bio-Nest Biochemical Technology Co., LTD
  • 7.4.1 Bio-Nest Biochemical Technology Co., LTD Company Information
  • 7.4.2 Bio-Nest Biochemical Technology Co., LTD Introduction and Business Overview
  • 7.4.3 Bio-Nest Biochemical Technology Co., LTD CeramideAP Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.4.4 Bio-Nest Biochemical Technology Co., LTD CeramideAP Product Offerings
• 7.5 Puripharm Co., Ltd.
  • 7.5.1 Puripharm Co., Ltd. Company Information
  • 7.5.2 Puripharm Co., Ltd. Introduction and Business Overview
  • 7.5.3 Puripharm Co., Ltd. CeramideAP Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.5.4 Puripharm Co., Ltd. CeramideAP Product Offerings

8 Industry Chain Analysis

• 8.1 CeramideAP Industrial Chain
• 8.2 CeramideAP Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 CeramideAP Production Technology
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 CeramideAP Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 CeramideAP Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer